Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case Report: Child with Menkes syndrome complicated by bladder diverticula. | Front Pediatr | 2025 | 40689217 | PubTator, text mining | PubMed |
| The copper chaperone ATOX1 exhibits differential protein-protein interactions and contributes to skeletal myoblast differentiation. | bioRxiv | 2025 | 40672323 | PubTator, text mining | PubMed |
| Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain. | J Integr Neurosci | 2025 | 40613364 | PubTator, text mining | PubMed |
| Cuproptosis: a novel therapeutic mechanism in lung cancer. | Cancer Cell Int | 2025 | 40555995 | PubTator, text mining | PubMed |
| Unveiling the Cuproptosis in Colitis and Colitis-Related Carcinogenesis: A Multifaceted Player and Immune Moderator. | Research (Wash D C) | 2025 | 40370501 | PubTator, text mining | PubMed |
| Exploring potential diagnostic markers and therapeutic targets for type 2 diabetes mellitus with major depressive disorder through bioinformatics and in vivo experiments. | Sci Rep | 2025 | 40369032 | PubTator, text mining | PubMed |
| Copper's new role in cancer: how cuproptosis-related genes could revolutionize glioma treatment. | BMC Cancer | 2025 | 40355831 | PubTator, text mining | PubMed |
| Discovery of P11-2: A Potent First-in-Class MNK1-Targeting PROTAC Degrader for the Treatment of Cancer. | J Med Chem | 2025 | 40334145 | PubTator, text mining | PubMed |
| Curcuminoids WM03 inhibits ovarian cancer cisplatin-resistant cells proliferation and reverses cisplatin resistance by targeting DYRK2. | Phytomedicine | 2025 | 40315643 | PubTator, text mining | PubMed |
| Dual MNK/VEGFR2 Inhibitor JDB153 Enhances Immunotherapeutic Efficiency and Chemosensitivity in Lung Cancer. | MedComm (2020) | 2025 | 40308810 | PubTator, text mining | PubMed |
| Cuproptosis, a potential target for the therapy of diabetic critical limb ischemia. | Free Radic Biol Med | 2025 | 40246253 | PubTator, text mining | PubMed |
| The MNK-SYNGAP1 axis in specific learning disorder: gene expression pattern and new perspectives. | Eur J Pediatr | 2025 | 40108041 | PubTator, text mining | PubMed |
| Clinical, biochemical and cell biological characterization of KIDAR syndrome associated with a novel AP1B1 variant. | Mol Genet Metab | 2025 | 40101690 | PubTator, text mining | PubMed |
| Acute GARP Depletion Disrupts Vesicle Transport, Leading to Severe Defects in Sorting, Secretion and O-Glycosylation. | Traffic | 2025 | 40100055 | PubTator, text mining | PubMed |
| Morpholino nicotinamide analogs of ponatinib, dual MNK, p70S6K inhibitors, display efficacy against lung and breast cancers. | Bioorg Chem | 2025 | 40081260 | PubTator, text mining | PubMed |
| TSC2 loss in neural progenitor cells suppresses mRNA translation of neurodevelopmental genes. | Brain | 2025 | 40037376 | PubTator, text mining | PubMed |
| Discovery of Potent and Selective MNK Kinase Inhibitors for the Treatment of Leukemia. | J Med Chem | 2025 | 40033556 | PubTator, text mining | PubMed |
| COMMD3 Regulates Copper Metabolism via the ATOX1-ATP7A-LOX Axis to Promote Multiple Myeloma Progression. | Biomedicines | 2025 | 40002764 | PubTator, text mining | PubMed |
| ATP7A as a prognostic biomarker and potential therapeutic target in gastric cancer. | Am J Transl Res | 2025 | 39959193 | PubTator, text mining | PubMed |
| Identification and characterization of cuproptosis related gene subtypes through multi-omics bioinformatics analysis in breast cancer. | Discov Oncol | 2025 | 39945992 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=7